Are there any new FDA-approved non-hormonal treatments for vasomotor symptoms that work as effectively as low-dose estrogen therapy for breast cancer survivors?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
Are there any new FDA-approved non-hormonal treatments for vasomotor symptoms that work as effectively as low-dose estrogen therapy for breast cancer survivors?
1 real search · 1 real-search pass
FDA approved nonhormonal treatments vasomotor symptoms 2025 2026 fezolinetant elinzanetant breast cancer survivors efficacy estrogen comparisonGoogle ↗
OBSERVEDComparison
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
ChatGPT real searches (1)
Classes come from the query-classifier (a local Laya model).
Searches and sources
ChatGPT1 real searches · gpt-6
FDA approved nonhormonal treatments vasomotor symptoms 2025 2026 fezolinetant elinzanetant breast cancer survivors efficacy estrogen comparison Google ↗
- Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer · nejm.org
- Drug Trials Snapshots: LYNKUET · fda.gov
- Bayer’s Lynkuet™ (elinzanetant) granted priority review by U.S. FDA for additional indication · bayer.com
- ACOG Clinical Practice Guideline: Management of... : Obstetrics & Gynecology · doi.org
- VA/DOD CLINICAL PRACTICE GUIDELINE FOR MENOPAUSE · healthquality.va.gov
- Hot Flashes and Night Sweats (PDQ®) · cancer.gov